KATHLEEN BYRNE: Open Payments
NPI 1215995667 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$393 in 4 payments from 3 companies in 2025. Trend: 2023 $744 · 2024 $606 · 2025 $393
Food & beverage: $393
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $245 |
| Regeneron Pharmaceuticals, Inc. | 1 | $101 |
| Novartis Pharmaceuticals Corporation | 1 | $47 |
Products named: REPATHA, EVKEEZA, LEQVIO.
Industry payments across MD — which companies pay providers there.
